                               SEQUENCE LISTING

<110> STAMATOYANNOPOULOS, JOHN A.
 
<120> METHODS AND COMPOSITIONS RELATED TO REGULATION OF NUCLEIC ACIDS

<130> 41299-760.601

<140> PCT/US13/58339
<141> 2013-09-05

<150> 61/697,200
<151> 2012-09-05

<160> 14    

<170> PatentIn version 3.5

<210> 1
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (2)..(2)
<223> a, c, t, g, unknown or other

<220>
<221> modified_base
<222> (4)..(4)
<223> a, c, t, g, unknown or other

<220>
<221> modified_base
<222> (6)..(6)
<223> a, c, t, g, unknown or other

<220>
<221> modified_base
<222> (8)..(8)
<223> a, c, t, g, unknown or other

<220>
<221> modified_base
<222> (10)..(13)
<223> a, c, t, g, unknown or other

<400> 1
ancngntnan nnncgt                                                       16


<210> 2
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Cys Pro Asp Cys Asp Met Ala Phe Val Thr Ser Gly Glu Leu Val Arg 
1               5                   10                  15      


<210> 3
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Thr Phe Gln Cys Glu Leu Cys Ser Tyr Thr Cys Pro Arg 
1               5                   10              


<210> 4
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Asn Ser Asp Leu Leu Thr Ser Pro Asp Val Gly Leu Leu Lys 
1               5                   10                  


<210> 5
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Asn Val Thr Asp Glu Gln Glu Gly Phe Ala Glu Gly Phe Val Arg 
1               5                   10                  15  


<210> 6
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Gln Asn Ala Leu Leu Glu Gln Gln Val Arg 
1               5                   10  


<210> 7
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Ala Thr Glu Tyr Ile Gln Tyr Met Arg 
1               5                   


<210> 8
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
gctagcctcg aggatatc                                                     18


<210> 9
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 9
aggccagatc ttgatatc                                                     18


<210> 10
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
actagtgcgc atgcgcaatg taca                                              24


<210> 11
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 11
ctgtcggcag agagacaaca ga                                                22


<210> 12
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 12
ctgttggcag agagacaaca ga                                                22


<210> 13
<211> 12
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (4)..(5)
<223> a, c, t, g, unknown or other

<220>
<221> modified_base
<222> (8)..(9)
<223> a, c, t, g, unknown or other

<400> 13
ccannagnng gc                                                           12


<210> 14
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (5)..(10)
<223> a, c, t, g, unknown or other

<400> 14
ctggnnnnnn gcca                                                         14


